Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$8.45 - $11.72 $131,929 - $182,984
-15,613 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$10.61 - $13.75 $24,806 - $32,147
2,338 Added 17.61%
15,613 $177,000
Q4 2020

Feb 16, 2021

SELL
$8.39 - $13.27 $18,592 - $29,406
-2,216 Reduced 14.31%
13,275 $144,000
Q2 2020

Aug 14, 2020

BUY
$6.65 - $9.84 $103,015 - $152,431
15,491 New
15,491 $149,000

Others Institutions Holding CSBR

About CHAMPIONS ONCOLOGY, INC.


  • Ticker CSBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,522,400
  • Market Cap $53.7M
  • Description
  • Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...
More about CSBR
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.